Warby Parker price to sales ratio WRBY

Market value divided by revenue over the last twelve months, since 2022.

Today, Oct 23, 2026: 3.5×
4-year median: 2.8×
Against its 4-year history: 78th; percentile: 0 is its lowest day, 100 its highest
4-year range: 1.8× to 4.5×
Peer median: 3.6×

Warby Parker's price to sales ratio is 3.5× as of Oct 23, 2026.

That is above its 4-year median of 2.8×, higher than on 78% of days in the last 4 years.

Over that time it ranged from 1.8× in Nov 2023 to 4.5× in Jan 2025.

The median for 10 medical instruments and supplies stocks of a similar size is 3.6×.

Price to sales ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.5×	2.8×	4.1×
2025	3.5×	2.2×	4.5×
2024	4.0×	2.1×	4.1×
2023	2.5×	1.8×	3.3×
2022	2.7×	2.5×	3.7×

Against its peers

Companies in Medical - Instruments & Supplies nearest Warby Parker's size, closest first, today.

Company	Price to sales ratio
WRBYWarby Parker	3.5×
ATRCAtriCure	5.3×
NVSTEnvista	1.3×
ICUIICU Medical	1.9×
BMIBadger Meter	5.0×
UFPTUFP Technologies	3.6×
VNTVontier	1.5×
INSPInspire Medical Systems	2.3×
LMATLemaitre Vascular	7.4×
HAEHaemonetics	4.0×
MMSIMerit Medical Systems	3.5×
Peer median	3.6×

Where Warby Parker ranks

#78of 116Medical instruments and supplies stocks with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Warby Parker

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.